Why Vitamin and Supplement Brands Face China's Strictest AI Visibility Test in 2026

Ask Doubao which multivitamin to buy and you will notice something that does not happen when you ask about sneakers or espresso machines: the model hedges. It cites certifications, adds disclaimers about consulting a doctor, and leans heavily on a small set of "safe" brand names. For international supplement brands like Swisse, Centrum, GNC, and Jamieson competing against domestic leader By-Health (汤臣倍健), this caution is not a quirk — it is the defining constraint of the category. In a market where Doubao alone reached 382 million monthly active users in the first half of 2026, per QuestMobile's mid-year rankings, how China's AI models handle health-adjacent queries now shapes which supplement brands enter the consumer's consideration set at all.

This article looks at why the vitamins, minerals, and health supplements (VMS) category behaves differently from every other consumer vertical we track, which brands are structurally advantaged, and what the "blue hat" registration system means for AI citation behavior.

A category where AI models are trained to be cautious

Chinese AI assistants treat supplement queries as sitting somewhere between shopping and medicine — and that ambiguity changes everything about how brands surface.

For most consumer categories, models like Doubao, Kimi, and DeepSeek behave as recommendation engines: they synthesize e-commerce reviews, social content, and editorial rankings into a shortlist. For supplements, two additional forces intervene. First, China's Advertisement Law and the health food regulations administered by the State Administration for Market Regulation (SAMR) sharply restrict what health claims can legally be made — supplements cannot claim to treat or prevent disease, and approved products carry the distinctive "blue hat" (蓝帽子) health food registration mark. Second, the model developers themselves apply extra safety alignment to health topics, since a hallucinated dosage or an overstated efficacy claim is a far bigger liability than a wrong phone recommendation.

The observable result across the six models we track (Doubao, Kimi, DeepSeek, Qwen, Wenxin, Hunyuan): supplement answers are shorter on superlatives, longer on disclaimers, and disproportionately anchored to brands with verifiable regulatory status and long-standing authority signals. Models fall back on what they can defend — and what they can defend is registration status, brand longevity, and presence on established third-party ranking sites.

Who wins under caution: the authority concentration effect

When models get cautious, they concentrate citations on fewer brands. The names that dominate Chinese AI answers in this category map closely to established authority lists like the 2026 CNPP top-brand rankings: By-Health (汤臣倍健), Swisse, Centrum (善存), Yangshengtang (养生堂), GNC, Caltrate (钙尔奇), Jamieson, 21 Super-Vita (21金维他), and Move Free.

Look at what these brands have in common, and the citation logic becomes clear:

Notice what is absent: the direct-to-consumer insurgent brands that have built real revenue on Douyin and xiaohongshu over the past three years. Livestream-native supplement brands can move hundreds of millions of yuan in GMV and still barely register in AI answers, because their footprint lives in short video and influencer content — formats that Chinese AI models cite far less readily than encyclopedia entries, third-party ranking sites, and established e-commerce category pages. In a cautious category, the citation gap between social-commerce success and AI visibility is wider than anywhere else we track.

The blue hat is becoming a machine-readable trust signal

The single most China-specific dynamic in this category is the blue hat registration mark. Every legally registered health food product in China carries it, along with a registration number searchable in SAMR's public database. For human shoppers, it has long been a package-label heuristic. For AI models, it is becoming something more useful: a structured, verifiable fact that a risk-averse model can safely state.

We consistently observe Chinese models — particularly Wenxin and Qwen, whose training and retrieval lean on Baidu Baike and Alibaba ecosystem data respectively — referencing registration status when asked comparative supplement questions. A brand whose product registrations, approved functional claims, and registration numbers are clearly documented across Baike entries, official brand sites, and e-commerce detail pages gives the model exactly the kind of defensible content it wants in a sensitive category.

This creates an unusual GEO situation: regulatory compliance documentation, normally the least glamorous content a brand produces, functions as high-value citation material. International brands selling through cross-border e-commerce channels face a structural disadvantage here — cross-border products do not require blue hat registration, which means they lack the very trust signal models most readily cite. Swisse partially overcomes this through sheer volume of authority coverage, but mid-tier international brands relying on cross-border channels are often invisible in exactly the queries where trust matters most.

Demographics compound the stakes

Two audience shifts make this category strategically urgent rather than niche. China's supplement market is a hundred-billion-yuan-class category propelled by an aging population, and the fastest-growing cohorts of Chinese AI users are precisely the demographics that buy supplements: middle-aged and senior users adopting Doubao through the Douyin ecosystem, and health-conscious younger consumers who treat AI assistants as a first-stop research tool before purchase.

The platform-role split we have documented across the Chinese AI landscape applies with extra force here. Doubao — with by far the largest and most mainstream user base — fields everyday consumer questions such as which calcium supplement suits an older parent. DeepSeek's user base, which skews technical and highly educated, produces more ingredient-level interrogation: bioavailability comparisons, dosage research, clinical evidence summaries. A brand can be well represented in Doubao's mainstream shortlists yet absent from the evidence-dense answers DeepSeek assembles, because the two models reach for different source layers. Optimizing for one does not automatically carry over to the other.

There is also a timing dimension. Health-topic safety alignment is tightening, not loosening: each major model release cycle in 2026 — DeepSeek's V4 line, Kimi's K-series updates, Doubao's paid Professional tier — has arrived with more conservative handling of medical-adjacent content, not less. Brands that establish authority positions now are effectively locking in placement in a shrinking answer window. As shortlists in cautious categories compress from five names to three, the difference between second and fourth place in a model's internal ranking becomes the difference between visibility and absence.

Takeaway for Brand Marketers

For supplement and VMS brands entering or defending the China market, the playbook differs meaningfully from other consumer categories:

Make your regulatory status machine-readable. If you hold blue hat registrations, ensure registration numbers, approved functional claims, and SAMR status are explicitly documented on your Chinese official site, Baidu Baike entry, and Tmall/JD product pages. This is the citation currency of a cautious category. If you sell cross-border without registration, compensate with third-party authority coverage — models need something verifiable to cite.

Prioritize third-party ranking presence over influencer volume. In most categories, social buzz eventually leaks into AI answers. In supplements, models discount influencer content and over-weight established ranking sites, pharmacy-channel coverage, and encyclopedic sources. Track where category top-10 lists live and ensure accurate brand representation there.

Audit the disclaimers, not just the mentions. In this category, how a model frames your brand matters as much as whether it appears. A mention wrapped in "efficacy is not clinically established" language is a different asset from one anchored to registration status and category leadership. Test the actual answer text across models, not just mention frequency.

Split your Doubao and DeepSeek strategies. Doubao's mainstream, older-skewing audience responds to trust and simplicity signals; DeepSeek's educated user base pulls ingredient- and evidence-level content. Brands with genuine clinical or formulation depth should publish it in citable, text-based Chinese formats — white papers, ingredient explainers on the official site — rather than leaving it locked in video.

The broader pattern is worth internalizing: as Chinese AI assistants become the first research step for health purchases, the categories where models are most cautious are the ones where authority-building compounds fastest. In supplements, there is no shortcut around trust infrastructure — and the brands that built it over decades are currently harvesting the AI visibility dividend.

Related: Explore brand-level scores across all six Chinese AI models on our brands page, or see our analysis of infant formula and maternity brands — another trust-gated category with similar dynamics.